This phase I trial investigates the safety of combining radiation, 5-fluorouracil (5-FU) and
cisplatin with the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib, in …

Background To evaluate the feasibility and efficiency of definitive concurrent
chemoradiotherapy (dCRT) with S-1 and cisplatin for elderly esophageal squamous cell …

Purpose The most effective treatments in elderly patients with esophageal cancer remain a
subject of debate. This multicenter phase 2 study was designed to evaluate the efficacy and …

Objectives: The objective of this study is to compare long-term outcomes between younger
and older (70 y and above) esophageal cancer patients treated with curative intent …

Aims and background Little is known about chemoradiotherapy in elderly patients with
locally advanced esophageal cancer. We compared the efficacy and toxicity of …

Background To analyse the outcome of elderly patients (≥ 70 years) with esophageal
cancer treated with curative intent radio (chemo) therapy. Methods Fifty five patients (median …

Purpose The aim of this study was to review the published literature addressing the question
of whether geriatric assessment (GA) should be routinely applied in the treatment of older …

Introduction: The benefit of definitive chemoradiotherapy (CRT) in elderly patients with
locally advanced esophageal cancer is not well established. We perform a single …

Purpose This study was designed to retrospectively analyze the safety and efficacy of
chemoradiation therapy with nedaplatin and 5-fluorouracil in elderly patients with …

Purpose The aim of this retrospective study is to evaluate the feasibility and efficacy of
concurrent chemoradiotherapy (CCRT) or sequential chemoradiotherapy (SCRT) with …